These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 32798842)

  • 81. Associations between Cerebrospinal Fluid Biomarkers and Cognition in Early Untreated Parkinson's Disease.
    Skogseth RE; Bronnick K; Pereira JB; Mollenhauer B; Weintraub D; Fladby T; Aarsland D
    J Parkinsons Dis; 2015; 5(4):783-92. PubMed ID: 26599300
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Mild cognitive impairment and cognitive-motor relationships in newly diagnosed drug-naive patients with Parkinson's disease.
    Poletti M; Frosini D; Pagni C; Baldacci F; Nicoletti V; Tognoni G; Lucetti C; Del Dotto P; Ceravolo R; Bonuccelli U
    J Neurol Neurosurg Psychiatry; 2012 Jun; 83(6):601-6. PubMed ID: 22492216
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Gray matter atrophy associated with mild cognitive impairment in Parkinson's disease.
    Chen FX; Kang DZ; Chen FY; Liu Y; Wu G; Li X; Yu LH; Lin YX; Lin ZY
    Neurosci Lett; 2016 Mar; 617():160-5. PubMed ID: 26742642
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson's disease].
    Homenko JG; Susin DS; Kataeva GV; Irishina JA; Zavolokov IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):46-51. PubMed ID: 28638030
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Incremental value of biomarker combinations to predict progression of mild cognitive impairment to Alzheimer's dementia.
    Frölich L; Peters O; Lewczuk P; Gruber O; Teipel SJ; Gertz HJ; Jahn H; Jessen F; Kurz A; Luckhaus C; Hüll M; Pantel J; Reischies FM; Schröder J; Wagner M; Rienhoff O; Wolf S; Bauer C; Schuchhardt J; Heuser I; Rüther E; Henn F; Maier W; Wiltfang J; Kornhuber J
    Alzheimers Res Ther; 2017 Oct; 9(1):84. PubMed ID: 29017593
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Mild Cognitive Impairment in Parkinson's Disease: Impact on Caregiver Outcomes.
    Szeto JY; Mowszowski L; Gilat M; Walton CC; Naismith SL; Lewis SJ
    J Parkinsons Dis; 2016 May; 6(3):589-96. PubMed ID: 27164044
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Mild cognitive impairment reverters have a favorable cognitive prognosis and cortical integrity in Parkinson's disease.
    Chung SJ; Park YH; Yoo HS; Lee YH; Ye BS; Sohn YH; Lee JM; Lee PH
    Neurobiol Aging; 2019 Jun; 78():168-177. PubMed ID: 30947112
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms.
    McDermott KL; Fisher N; Bradford S; Camicioli R
    Int Psychogeriatr; 2018 Feb; 30(2):253-260. PubMed ID: 29094664
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Progression of subcortical atrophy in mild Parkinson's disease and its impact on cognition.
    Foo H; Mak E; Yong TT; Wen MC; Chander RJ; Au WL; Sitoh YY; Tan LC; Kandiah N
    Eur J Neurol; 2017 Feb; 24(2):341-348. PubMed ID: 27943468
    [TBL] [Abstract][Full Text] [Related]  

  • 90. [Mild cognitive impairment in Parkinson's disease].
    Wada K; Nakashima K
    Brain Nerve; 2012 Dec; 64(12):1365-75. PubMed ID: 23209063
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Aberrant voxel-based degree centrality in Parkinson's disease patients with mild cognitive impairment.
    Li MG; Bian XB; Zhang J; Wang ZF; Ma L
    Neurosci Lett; 2021 Jan; 741():135507. PubMed ID: 33217504
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Prediction of Cognitive Degeneration in Parkinson's Disease Patients Using a Machine Learning Method.
    Chen PH; Hou TY; Cheng FY; Shaw JS
    Brain Sci; 2022 Aug; 12(8):. PubMed ID: 36009111
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Application of Periventricular White Matter Hyperintensities Combined with Homocysteine into Predicting Mild Cognitive Impairment in Parkinson's Disease.
    Zhang Z; Li S; Wang S
    Int J Gen Med; 2023; 16():785-792. PubMed ID: 36879618
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Accuracy of Machine Learning Using the Montreal Cognitive Assessment for the Diagnosis of Cognitive Impairment in Parkinson's Disease.
    Jeon J; Kim K; Baek K; Chung SJ; Yoon J; Kim YJ
    J Mov Disord; 2022 May; 15(2):132-139. PubMed ID: 35670022
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Machine learning for the detection and diagnosis of cognitive impairment in Parkinson's Disease: A systematic review.
    Altham C; Zhang H; Pereira E
    PLoS One; 2024; 19(5):e0303644. PubMed ID: 38753740
    [TBL] [Abstract][Full Text] [Related]  

  • 96. The sound of Parkinson's disease: A model of audible bradykinesia.
    de Graaf D; Araújo R; Derksen M; Zwinderman K; de Vries NM; IntHout J; Bloem BR
    Parkinsonism Relat Disord; 2024 Mar; 120():106003. PubMed ID: 38219529
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cognitive Determinants of Dysarthria in Parkinson's Disease: An Automated Machine Learning Approach.
    García AM; Arias-Vergara T; C Vasquez-Correa J; Nöth E; Schuster M; Welch AE; Bocanegra Y; Baena A; Orozco-Arroyave JR
    Mov Disord; 2021 Dec; 36(12):2862-2873. PubMed ID: 34390508
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Trends and issues in characterizing early cognitive changes in Parkinson's disease.
    Claassen DO; Wylie SA
    Curr Neurol Neurosci Rep; 2012 Dec; 12(6):695-702. PubMed ID: 22949166
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Bayesian Optimization with Support Vector Machine Model for Parkinson Disease Classification.
    Elshewey AM; Shams MY; El-Rashidy N; Elhady AM; Shohieb SM; Tarek Z
    Sensors (Basel); 2023 Feb; 23(4):. PubMed ID: 36850682
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Retinal Imaging Techniques Based on Machine Learning Models in Recognition and Prediction of Mild Cognitive Impairment.
    Zhang Q; Li J; Bian M; He Q; Shen Y; Lan Y; Huang D
    Neuropsychiatr Dis Treat; 2021; 17():3267-3281. PubMed ID: 34785897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.